Predictive Oncology Inc. (POAI)

NASDAQ: POAI · IEX Real-Time Price · USD

1.020

-0.010 (-0.97%)

At close: Jul 2, 2024, 4:00 PM

1.030

+0.010 (0.98%)

After-hours: Jul 2, 2024, 7:51 PM EDT

Predictive Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2007
Net Income	-13.98	-25.74	-19.66	-26.44	-19.68	Upgrade
Depreciation & Amortization	0.74	1.31	1.34	1.02	0.7	Upgrade
Share-Based Compensation	0	0.17	0.72	0.72	2.25	Upgrade
Other Operating Activities	0.05	11.89	5.39	11.88	7.7	Upgrade
Operating Cash Flow	-13.19	-12.37	-12.21	-12.26	-8.73	Upgrade
Capital Expenditures	-0.28	-0.42	-0.91	-0.11	-0.01	Upgrade
Acquisitions	0	0	-9.59	0	0.25	Upgrade
Change in Investments	0	0	-0.06	0	-0.82	Upgrade
Other Investing Activities	-0.03	-0.06	-0.05	-0.06	-0.02	Upgrade
Investing Cash Flow	-0.3	-0.48	-10.61	-0.17	-0.6	Upgrade
Share Issuance / Repurchase	-0	6.72	55.7	6.83	0.33	Upgrade
Debt Issued / Paid	0.15	0	-4.16	1.29	1.54	Upgrade
Other Financing Activities	-	-	-1.2	4.84	7.46	Upgrade
Financing Cash Flow	0.15	6.72	50.34	12.95	9.32	Upgrade
Net Cash Flow	-13.34	-6.13	27.52	0.53	-0.01	Upgrade
Free Cash Flow	-13.47	-12.79	-13.12	-12.36	-8.74	Upgrade
Free Cash Flow Margin	-756.46%	-849.62%	-923.46%	-987.23%	-619.05%	Upgrade
Free Cash Flow Per Share	-3.35	-3.47	-4.78	-20.69	-60.89	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).